Seeing Is Believing
Currently out of the existing stock ratings of Scott Bardo, 24 are a BUY (96%), 1 are a HOLD (4%).
Analyst Scott Bardo, currently employed at BERENBERG, carries an average stock price target met ratio of 33.33% that have a potential upside of 7.94% achieved within 98 days.
Scott Bardo’s has documented 52 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QGEN, Qiagen NV at 02-Mar-2023.
Analyst best performing recommendations are on ALC (ALCON AG).
The best stock recommendation documented was for QGEN (QIAGEN NV) at 1/16/2019. The price target of $41.12 was fulfilled within 76 days with a profit of $4.48 (12.23%) receiving and performance score of 1.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$120
$30.39 (33.91%)
$105
19 days ago
(28-Mar-2025)
8/10 (80%)
$24.23 (25.30%)
338
Buy
$110
$20.39 (22.75%)
$107
19 days ago
(28-Mar-2025)
15/25 (60%)
$14.23 (14.86%)
393
Buy
$108
$18.39 (20.52%)
$110
1 months 20 days ago
(27-Feb-2025)
7/10 (70%)
$16.03 (17.43%)
282
Buy
4 months 21 days ago
(26-Nov-2024)
3/3 (100%)
$13.18 (18.28%)
289
Buy
$106
$16.39 (18.29%)
$104
6 months 2 days ago
(14-Oct-2024)
8/10 (80%)
$8.8 (9.05%)
108
What Year was the first public recommendation made by Scott Bardo?